In this issue:
Nicotinamide for skin-cancer chemoprevention
Neoadjuvant + adjuvant or adjuvant-only in advanced melanoma
Brain metastasis and survival outcomes
Efficacy and toxicity of adjuvant radiotherapy
Skin cancer surveillance after childhood cancer
Response to immune checkpoint inhibitors in metastatic MCC
Next-generation sequencing mutational analysis
MIA and MSKCC in selecting patients with melanoma for lymph node biopsy
Cutaneous immune-related adverse events and overall survival
Survival and tumour characteristics in melanoma lesions
Please login below to download this issue (PDF)